常州市存仁生物工程有限公司

产品 > Others > > LY335979
产品名称 : LY335979
型号 : CRY905
CAS : 167354-41-8
备注:所有产品仅用作科学研究,我们不为任何个人用途提供产品和服务 : 
 放大                   返回
←[上一个产品]              [下一个产品]→


产品详细:
Description of:LY335979
LY335979 significantly enhanced the survival of mice implanted with Pgp-expressing murine leukemia (P388/ADR) when administered in combination with either daunorubicin, doxorubicin or etoposide. Coadministration of LY335979 with paclitaxel compared to paclitaxel alone significantly reduced the tumor mass of the Pgp-expressing UCLA-P3.003VLB lung carcinoma in a xenograph model. 

Theoretical analysis:LY335979
M.Wt: 527.6
Formula: C32H31F2N3O2
Solubility: Unknown
Purity: >99%
Storage: at -20
CAS No: 167354-41-8

Availability and price:LY335979
Pakage:25mg/50mg/100mg/250mg/500mg/1g/5g
Stock : in stock
We offer significant discount for larger quantity order.
For quotation, question, and order, please send email to : 
sales@chemrenpharm.com
Quality control data:
Quality Control by H-NMR,C-NMR,LC-MS,HPLC.
Product will be shipped with supporting analytical data.
Fast delivery about 4-5 working days


相关产品 :
APD-597(JNJ-38431055)
APD-597(JNJ-38431055)
Altiratinib(DCC-2701)
Altiratinib(DCC-2701)
Selamectin
Selamectin
AZD8186
AZD8186
AGI-5198
AGI-5198
JWH 133
JWH 133
LMK-235
LMK-235
Vipadenant(BIIB 014)
Vipadenant(BIIB 014)

在线联系

点击这里给我发消息